Danaher Corporation vs Lamb Weston Holdings Inc — how do they compare? Danaher Corporation trades at $201.01 (market cap $140.88B), while Lamb Weston Holdings Inc trades at $45.61 (market cap $6.42B). The key difference: Danaher Corporation is far larger — about 21.9× Lamb Weston Holdings Inc's market cap, and Lamb Weston Holdings Inc pays the higher dividend (3.27%). Which is the better fit depends on your goals.
| DHR | LW | |
|---|---|---|
Market Cap | $140.88B | $6.42B |
Sector | Health | Consumer Staples |
52-Week High | $242.05 | $66.57 |
52-Week Low | $161.91 | $38.48 |
Enterprise Value | $153.66B | $10.38B |
Dividend Yield | 0.8% | 3.27% |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $199.05, down 0.55% today, with a bullish technical outlook supported by moving averages and a consensus price target of $211.33. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.06 exceeding expectations. Revenue for 2025 was $24.57 billion, with a net income margin of 14.89%, though margins have declined from 2022 levels. Recent news includes the acquisition of Masimo and strong biotechnology segment performance.
The stock presents a favorable risk-reward profile with analyst support (69% buy ratings) and solid cash flow generation, but faces risks from margin compression and a high P/E ratio of 38.58. Upside is driven by earnings beats and strategic acquisitions, while headwinds include competitive pressures and macroeconomic uncertainty. The current price near $199 offers modest upside to the consensus target, with key resistance at $200.
Lamb Weston (LW) trades at $46.98, up 1.14% with a bullish technical signal and consistent earnings beats. The company shows strong operational cash flow of $868.3M in 2025 and maintains positive revenue growth, though net income margin declined to 4.61%. Recent news highlights the 'Focus to Win' strategy showing early traction with North America volume gains and cost savings.
Outlook remains cautiously optimistic with analyst consensus price target of $49.33 offering 5% upside. Key risks include ongoing securities litigation and margin pressure from competitive dynamics. Institutional sentiment leans positive with activist involvement signaling potential value creation opportunities.
Trailing returns across standard periods
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Lamb Weston is the world's second-largest producer of branded and private-label frozen potato products, such as French fries, sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. The company also has a small appetizer business that produces onion rings, mozzarella sticks, and cheese curds. Including joint ventures, 63% of fiscal 2022 revenue was U.S.-based, with the remainder stemming from Europe, Canada, Japan, China, Korea, Mexico, and several other countries. Lamb Weston's customer mix is estimated 58% quick-serve restaurants, 19% full-service restaurants, 8% other food services (hotels, commercial cafeterias, arenas, schools), and 16% retail. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
Read more on LW →